Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/14/2003CA2475055A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003CA2474652A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473144A1 Protein purification
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/13/2003EP1335024A1 Antibody inhibiting vplf activity
08/13/2003EP1335022A1 Modification of plant cell wall component and method of regulating development differentiation
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
08/13/2003EP1334983A2 Inhibitory, monoclonal antibody against the protease which activates clotting factor VII
08/13/2003EP1334979A1 Gene conferring resistance to Phytophthera infestans (late-blight) in Solanaceae
08/13/2003EP1334731A1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
08/13/2003EP1334730A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/13/2003EP1334659A1 Pd-1-lacking mouse and use thereof
08/13/2003EP1334196A2 Genomic fragment of streptococcus suis and clinical uses thereof
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334191A2 Human g-protein coupled receptor and uses thereof
08/13/2003EP1334190A2 Human g-protein coupled receptor and uses thereof
08/13/2003EP1334188A2 Cd19-specific redirected immune cells
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain
08/13/2003EP1334131A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334122A2 Nucleic acids encoding stichodactylidae chromoproteins
08/13/2003EP1333860A1 Antibodies to the propeptide of candida albicans and methods of use
08/13/2003EP1333859A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1112495B1 Disaccharide derivatives
08/13/2003EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
08/13/2003EP1053473A4 Method and apparatus for detecting conception in animals
08/13/2003EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0556344B1 New insulin-like growth factor binding protein
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436239A Novel enzyme gene and its expression product
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436236A Gasci基因 Gasci gene
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1436095A Simulated activity of protein A displayed by ligands attached to cellulose bead surface
08/13/2003CN1435485A Recombinant DNA sequence, coded immune fusion protein and expression method
08/13/2003CN1117763C Anti-alphaV-integrin monoclonal antibody
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/12/2003US6605705 Prostaglandin D synthase-specific monoclonal antibody
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605456 Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases
08/12/2003US6605455 Polynucleotides used to transform or transfect cells; gene expression
08/12/2003US6605448 Filamentous bacteriophage with genetically engineered insert of oligonucleotide population; vectors; gene expression
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605442 Methods of testing drugs or agents that modulate the activity of receptor recognition factors
08/12/2003US6605441 Antibodies against fibroblast growth factor 11
08/12/2003US6605437 Screening methods for compounds useful for the treatment of body weight disorders, including obesity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/12/2003US6605278 Uses of trank, a novel secretory cytokine
08/12/2003US6605277 Conformation-specific anti-von Willebrand factor antibodies
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003CA2248653C Vaccines for treatment of lymphoma and leukemia
08/12/2003CA2116888C Human anti-tnf antibodies
08/07/2003WO2003065003A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
08/07/2003WO2003064992A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064662A1 Bispecific molecules cross-linking itim and itam for therapy of allergies
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064475A1 Novel monoclonal antibody and nematode larval antigens
08/07/2003WO2003064474A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
08/07/2003WO2003064473A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003063906A1 Drugs for treating inflammatory diseases
08/07/2003WO2003063904A2 Tissue adhesion formation control
08/07/2003WO2003063899A2 Vaccine adjuvant based on a cd4 0 ligand
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063768A2 Compositions and methods directed to anthrax toxin
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063575A2 Endothelialization of vascular surfaces
08/07/2003WO2003046556A3 Globin biopolymer markers indicative of insulin resistance
08/07/2003WO2003042366A3 A novel saitohin gene and uses of same
08/07/2003WO2003040340A9 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
08/07/2003WO2003000271A8 System and method for the large scale labeling of compounds with radiohalogens
08/07/2003WO2002096948A3 Engineered tetravalent antibodies and methods of use
08/07/2003WO2002077179A3 Leinamycin biosynthesis gene cluster and its components and their uses
08/07/2003WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
08/07/2003WO2002066059A3 Agents that specifically block cd28-mediated signaling and uses therefor
08/07/2003WO2002057457A3 Human proteins 55562 and 21617, and methods of use thereof
1 ... 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 ... 1494